First Page | Document Content | |
---|---|---|
Date: 2014-05-29 13:51:55Hepatitis Non-alcoholic fatty liver disease Steatohepatitis Fatty liver Metformin Cirrhosis Insulin resistance Chronic liver disease Liver biopsy Medicine Health Hepatology | Microsoft PowerPoint - Kohli - NASH.pptxAdd to Reading ListSource URL: www.naspghan.orgDownload Document from Source WebsiteFile Size: 718,31 KBShare Document on Facebook |
Obeticholic Acid for the Treatment of Nonalcoholic Steatohepatitis: Comparative Clinical Effectiveness and Value Draft Evidence Report May 25, 2016 Institute for Clinical and Economic ReviewDocID: 1nwXZ - View Document | |
doi:j.jhepDocID: 1fsCV - View Document | |
New York PREPARED BY THE CENTER FOR HEALTH LAW AND POLICY INNOVATION OF HARVARD LAW SCHOOL New YorkDocID: 1aoGf - View Document | |
Final report 2008 Review of Hepatitis CDocID: 188J8 - View Document | |
NASH associated with a 50 percent higher chance of death compared with NAFLDDocID: 17AQx - View Document |